EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases

Friederike Oltmanns, Ana Vieira Antão, Pascal Irrgang, Vera Viherlehto, Leticia Jörg, Anna Schmidt, Jannik T Wagner, Michael Rückert, Ann-Sophie Flohr, Carol Imanuel Geppert, Benjamin Frey iD, Wibke Bayer und 4 weitere

Journal for ImmunoTherapy of Cancer · 2024

DOI: 10.1136/jitc-2023-008652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2024. Verfasst von Friederike Oltmanns und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany. Hauptthemen laut MEDLINE: Cancer Vaccines, Lung Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Interdisciplinary Center for Clinical Research, Deutsche Forschungsgemeinschaft, Doktor Robert Pfleger-Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Generally, early-stage breast cancer has a good prognosis. However, if it spreads systemically, especially with pulmonary involvement, prospects worsen dramatically. Importantly, tumor-infiltrating T cells contribute to tumor control, particularly intratumoral T cells with a tissue-resident memory phenotype are associated with an improved clinical outcome.

Methods

Here, we use an adenoviral vector vaccine encoding endogenous tumor-associated antigens adjuvanted with interleukin-1β to induce tumor-specific tissue-resident memory T cells (TRM) in the lung for the prevention and treatment of pulmonary metastases in the murine 4T1 breast cancer model.

Results

The mucosal delivery of the vaccine was highly efficient in establishing tumor-specific TRM in the lung. Concomitantly, a single mucosal vaccination reduced the growth of pulmonary metastases and improved the survival in a prophylactic treatment. Vaccine-induced TRM contributed to these protective effects. In a therapeutic setting, the vaccination induced a pronounced T cell infiltration into metastases but resulted in only a minor restriction of the disease progression. However, in combination with stereotactic radiotherapy, the vaccine increased the survival time and rate of tumor-bearing mice.

Conclusion

In summary, our study demonstrates that mucosal vaccination is a promising strategy to harness the power of antitumor TRM and its potential combination with state-of-the-art treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesLung NeoplasmsAnimalsMiceAntigens, NeoplasmImmunologic MemoryVaccination

Stichwörter der Autor:innen

adjuvantbreast cancermemoryradiotherapy/radioimmunotherapyvaccine

Substanzen

Antigens, NeoplasmCancer Vaccines

Autor:innen und Institutionen

  • Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Translational Radiobiology, Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Comprehensive Cancer Center Erlangen-EMN (CCC), University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • FAU Profile Center Immunomedicine (FAU I-MED), Friedrich-Alexander-Universität Erlangen-Nuremberg, Erlangen, Germany.
  • Institute for Virology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

ORCID-Profile: Benjamin Frey, Udo Gaipl, Dennis Lapuente

Förderung

  • Interdisciplinary Center for Clinical Research
  • Deutsche Forschungsgemeinschaft
  • Doktor Robert Pfleger-Stiftung

Zitieren

APA

Oltmanns, F., Vieira Antão, A., Irrgang, P., Viherlehto, V., Jörg, L., Schmidt, A., Wagner, J. T., Rückert, M., Flohr, A. S., Geppert, C. I., Frey, B., Bayer, W., Gravekamp, C., Tenbusch, M., Gaipl, U., & Lapuente, D. (2024). Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2023-008652

Vancouver

Oltmanns F, Vieira Antão A, Irrgang P, Viherlehto V, Jörg L, Schmidt A, et al. Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases. Journal for ImmunoTherapy of Cancer. 2024. doi:10.1136/jitc-2023-008652

BibTeX
@article{Oltmanns2024,
  author = {Oltmanns, Friederike and Vieira Antão, Ana and Irrgang, Pascal and Viherlehto, Vera and Jörg, Leticia and Schmidt, Anna and Wagner, Jannik T and Rückert, Michael and Flohr, Ann-Sophie and Geppert, Carol Imanuel and Frey, Benjamin and Bayer, Wibke and Gravekamp, Claudia and Tenbusch, Matthias and Gaipl, Udo and Lapuente, Dennis},
  title = {Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2024},
  doi = {10.1136/jitc-2023-008652}
}
Kostenlos starten →